LifeMD, Inc. (LFMD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LFMD Revenue Growth
Revenue Breakdown (FY 2025)
LFMD's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
LFMD Revenue Analysis (2014–2025)
As of May 8, 2026, LifeMD, Inc. (LFMD) generated trailing twelve-month (TTM) revenue of $219.4 million, reflecting significant decline in growth of -23.6% year-over-year. The most recent quarter (Q1 2026) recorded $50.2 million in revenue, up 7.0% sequentially.
Looking at the longer-term picture, LFMD's 5-year compound annual growth rate (CAGR) stands at +39.1%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $212.5 million in 2024.
Revenue diversification analysis shows LFMD's business is primarily driven by Product and Services (100%). With over half of revenue concentrated in Product and Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HIMS (+59.0% YoY), NUVB (+1205.5% YoY), and DOCS (+15.9% YoY), LFMD has underperformed the peer group in terms of revenue growth. Compare LFMD vs HIMS →
LFMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LFMDCurrent | $219M | -23.6% | +39.1% | -4.0% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 NUVB | $63M | +1205.5% | - | -338.7% | |
 DOCS | $570M | +15.9% | +37.4% | 39.9% | |
 OPRX | $109M | +18.8% | +20.4% | 10.7% | |
 TDOC | $2.5B | -1.5% | +18.3% | -10.4% |
LFMD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $194.1M | -8.7% | $154.8M | 79.8% | $-7,669,694 | -4.0% |
| 2024 | $212.5M | +39.3% | $188.4M | 88.7% | $-16,144,681 | -7.6% |
| 2023 | $152.5M | +28.2% | $133.6M | 87.6% | $-14,489,273 | -9.5% |
| 2022 | $119.0M | +28.2% | $100.4M | 84.3% | $-43,447,781 | -36.5% |
| 2021 | $92.9M | +149.0% | $74.9M | 80.6% | $-54,301,081 | -58.5% |
| 2020 | $37.3M | +199.1% | $28.4M | 76.2% | $-57,819,453 | -155.0% |
| 2019 | $12.5M | +49.8% | $9.9M | 79.7% | $-2,889,608 | -23.2% |
| 2018 | $8.3M | +64.7% | $6.4M | 76.3% | $-2,056,140 | -24.7% |
| 2017 | $5.1M | -3.5% | $3.6M | 70.6% | $-1,067,534 | -21.1% |
| 2016 | $5.2M | +329.8% | $3.3M | 62.9% | $-1,174,682 | -22.4% |
See LFMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LFMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LFMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLFMD — Frequently Asked Questions
Quick answers to the most common questions about buying LFMD stock.
Is LFMD's revenue growth accelerating or slowing?
LFMD revenue declined -23.6% year-over-year, contrasting with the 5-year CAGR of +39.1%. TTM revenue fell to $219M. This reverses the prior growth trend.
What is LFMD's long-term revenue growth rate?
LifeMD, Inc.'s 5-year revenue CAGR of +39.1% reflects the variable expansion pattern. Current YoY growth of -23.6% is below this long-term average.
How is LFMD's revenue distributed by segment?
LFMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.